Cube Labs
VC Fund
Rome, Italy
Cube Labs is a VC fund in Rome focused on Wellness and Health Care. They are venture builders enabling innovation in the healthcare technology space. They build companies from promising early-stage R&D and provide entrepreneurial and operational support at all the stages of their life cycle to transform pioneering science into healthcare solutions.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Cube Labs invests in
Stages Cube Labs invests in
Countries Cube Labs invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Investment Focus
Industry
- Wellness 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chris Hentschel
Chief Scientific Officer
|
Chief Scientific Officer | Total investments: 0 | Find email | |
Daria Brambilla
Executive Scientific Manager
|
Executive Scientific Manager | Total investments: 0 | Find email | |
Filippo Surace
Founder & CEO
|
Founder & CEO | Total investments: 1 | Find email | |
Natalie Pankova
Chief Operating Officer
|
Chief Operating Officer | Total investments: 2 | Find email | |
Neil Thomas
Chief Business Officer
|
Chief Business Officer | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Adamas Biotech
|
Adamas Biotech develops clinically validated, nutraceutical-based prophylactic and therapeutic solutions for clinical and wellness indications. They offer evidence-based medicine and access to the scientific methods integral to creating innovative solutions in the nutraceutical field. Through their unique scientific-nutraceutical approach, theyutilize raw materials with clinically validated biological activities. They provide antioxidant, anti-angiogenic, and anti-inflammatory properties of green tea extracts for the treatment of high-grade intraepithelial neoplasia and for blocking its progression into prostate cancer. | $131.6K / Corporate Round / May 09, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Cube Labs invest in?
Cube Labs invests primarily in Wellness, Health Care and Biotechnology startups, most often at Corporate Round stage. Most of the 1 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cube Labs?
Public channels for Cube Labs include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cube Labs?
The team at Cube Labs includes Chris Hentschel (Chief Scientific Officer), Daria Brambilla (Executive Scientific Manager) and Filippo Surace (Founder & CEO), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
